MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Opioid dependence with intoxication, uncomplicated (F11.220)

Evalytics 22 December at 02.27 PM

Could a little-known psychedelic drug treat opioid addiction? Kentucky wants to find out.

Kentucky is seeking federal approval to study ibogaine, a psychedelic drug from West Africa, as a potential treatment for opioid addiction. Ibogaine has shown promise in reducing withdrawal symptoms and cravings, presenting an alternative approach to traditional addiction treatments.

HealthDay 21 December at 11.17 PM

FDA Approves DNA Cheek Swab Test to ID Patients at High Risk for Opioid Addiction

The U.S. Food and Drug Administration has approved a first-of-its-kind test -- the AvertD test -- that uses DNA swabbed from a patient's cheek to determine if they have a combination of genetic variants associated with an elevated risk for opioid addiction.The 15 genetic variants detected by the test are involved in the brain reward pathways t

Evalytics 18 December at 05.42 PM

Could a little-known psychedelic drug treat opioid addiction? Kentucky wants to find out.

Kentucky is launching a pilot program to study the use of the psychedelic drug ibogaine as a potential treatment for opioid addiction, despite its federal illegality. Derived from a West African shrub, ibogaine shows promise in combating the opioid crisis, and this initiative seeks to assess its effectiveness and safety.

Evalytics 31 October at 04.46 PM

Telemedicine for Buprenorphine Initiation: Revolutionizing Opioid Use Disorder Treatment

In recent years, the healthcare industry has witnessed a transformative shift towards telemedicine. This innovative approach to healthcare delivery has proven to be not only convenient but also highly effective, especially in addressing complex issues like opioid use disorder. In this article, we will explore how telemedicine has revolutionized the initiation of buprenorphine treatment for individ